Results from Novavax vaccine trials in the UK and South Africa differ: why, and does it matter?

The efficacy of the vaccine was 89 per cent in United Kingdom and 60 per cent in South Africa

COVID-19 herd immunity? It’s not going to happen, so what next?

The only sustainable solution is to learn to live with the virus.